S100A9 and rheumatoid arthritis: In simple linear regression analysis, we found that serum levels of S100A9 in RA patients were positively associated with the presence of the PTPN22 Cys1858Thr genetic polymorphism, serum levels of S100A12, and serum levels of S100A8 (Table 2, P < 0.05).